High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon

dc.contributor.authorRodrigues, Eliene Putira Sacuema
dc.contributor.authorAbreu, Isabella Nogueira
dc.contributor.authorLima, Carlos Neandro Cordeiro
dc.contributor.authorFonseca, Dennyson Leandro Mathias da
dc.contributor.authorPereira, Sávio Felipe Gomes
dc.contributor.authorReis, Laena Costa dos
dc.contributor.authorVallinoto, Izaura Maria Vieira Cayres
dc.contributor.authorGuerreiro, João Farias
dc.contributor.authorVallinoto, Antonio Carlos Rosário
dc.date.accessioned2021-04-27T02:26:20Z
dc.date.available2021-04-27T02:26:20Z
dc.date.issued2021-01-28
dc.descriptionPMID: 33509206 PMCID: PMC7841757
dc.description.abstractThe COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reached the Brazilian Amazon and spread among indigenous populations. In the present study, we demonstrate a high prevalence of infection among the Xikrin of Bacajá people (Kayapó). A sample of 100 individuals of both sexes (51 men and 49 women) with ages ranging from 2 to 82 years were clinically evaluated and tested for the presence of anti-SARS-CoV-2 IgG antibody. Among all investigated individuals, 58 were IgG-reactive (58 %) by a rapid test, and 73 (73 %) were reactive in an enzyme-linked immunosorbent assay, with no difference between sexes. Oxygen saturation ranged from 82 to 99 %, with the lowest value observed in a two-year-old girl. The results show that as expected, SARS-CoV-2 infection rapidly reached more than 70 % of the population, most likely because of the difficulties of maintaining social distance due to cultural characteristics. These results highlight the importance of indigenous health policies as a means of minimizing the impact of the pandemic on these communities.
dc.identifier.citationRODRIGUES, E. P. S.; et al. High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon. Int J Equity Health, v. 20, n. 1, p. 50, jan. 2021. doi:10.1186/s12939-021-01392-8. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33509206/. Acesso em: 7 mar. 2021
dc.identifier.doi10.1186/s12939-021-01392-8
dc.identifier.issn1475-9276
dc.identifier.urihttps://repositorio.bvspovosindigenas.fiocruz.br/handle/bvs/4083
dc.language.isoeng
dc.publisherBMC [Commercial Publisher] International Society for Equity in Health [Associate Organisation]
dc.rightsopen access
dc.source; C:\Users\Rita\Zotero\storage\HE2C33EL\Rodrigues et al. - 2021 - High prevalence of anti-SARS-CoV-2 IgG antibody in.pdf
dc.subject.decsBrasil
dc.subject.decsÍndios Sul-Americanos
dc.subject.decsPolíticas Públicas de Saúde
dc.subject.decsSaúde de Populações Indígenas
dc.subject.decsCovid-19
dc.subject.otherAmazonas
dc.subject.otherRegião Amazônica
dc.subject.otherRegião Norte
dc.subject.otherKayapó
dc.subject.otherXikrin
dc.titleHigh prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Rodrigues et al. - 2021 - High prevalence of anti-SARS-CoV-2 IgG antibody in.pdf
Size:
386.87 KB
Format:
Adobe Portable Document Format